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RASA3 is a Ras GTPase activating protein that plays a critical role in blood
formation. The autosomal recessive mouse model scat (severe combined anemia and
thrombocytopenia) carries a missense mutation in Rasa3. Homozygotes present with
a phenotype characteristic of bone marrow failure that is accompanied by alternating
episodes of crisis and remission. The mechanism leading to impaired erythropoiesis and
peripheral cell destruction as evidenced by membrane fragmentation in scat is unclear,
although we previously reported that the mislocalization of RASA3 to the cytosol of
reticulocytes and mature red cells plays a role in the disease. In this study, we further
characterized the bone marrow failure in scat and found that RASA3 plays a central
role in cell cycle progression and maintenance of reactive oxygen species (ROS) levels
during terminal erythroid differentiation, without inducing apoptosis of the precursors. In
scat mice undergoing crises, there is a consistent pattern of an increased proportion of
cells in the G0/G1 phase at the basophilic and polychromatophilic stages of erythroid
differentiation, suggesting that RASA3 is involved in the G1 checkpoint. However,
this increase in G1 is transient, and either resolves or becomes indiscernible by the
orthochromatic stage. In addition, while ROS levels are normal early in erythropoiesis,
there is accumulation of superoxide levels at the reticulocyte stage (DHE increased
40% in scat; p = 0.02) even though mitochondria, a potential source for ROS, are
eliminated normally. Surprisingly, apoptosis is significantly decreased in the scat bone
marrow at the proerythroblastic (15.3%; p = 0.004), polychromatophilic (8.5%; p = 0.01),
and orthochromatic (4.2%; p = 0.02) stages. Together, these data indicate that ROS
accumulation at the reticulocyte stage, without apoptosis, contributes to the membrane
fragmentation observed in scat. Finally, the cell cycle defect and increased levels of
ROS suggest that scat is a model of bone marrow failure with characteristics of aplastic
anemia.
Keywords: erythropoiesis, mouse models, anemia, aplastic, bone marrow failure syndromes, reactive oxygen
species (ROS), cell cycle, apoptosis
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INTRODUCTION
Every day, a healthy individual’s bone marrow produces 200
billion erythrocytes in the process of erythropoiesis. Bone
marrow failure syndromes (BMFS) are a diverse group of
inherited or acquired disorders characterized by varying degrees
of hematopoietic failure and a predisposition to hematologic
malignancies (Shimamura and Alter, 2010). While targetable
molecular markers associated with the various subclasses
of BMFS have recently been identified, the full molecular
pathogeneses of these diseases are likely a complex interaction
between genetic changes at the hematopoietic stem cell level
and alterations in the hematopoietic niche of the bone marrow
itself, and these mechanisms have yet to be fully elucidated
(Rankin et al., 2015). Aplastic anemia (AA) is one of the most
commonly diagnosed BMFS, with over 2,500 new cases each year
in North America and in Europe alone, and is characterized
by a hypocellular bone marrow and ineffective hematopoiesis
of the erythroid, megakaryocyte, and granulocyte/monocyte
lineages (Guinan, 2011; Bodine and Berliner, 2014). At the
molecular level, AA is characterized by increased levels of
reactive oxygen species (ROS) and defective DNA repair
mechanisms (Khincha and Savage, 2013; Richardson et al.,
2015).
Like most BMFS, AA can either be acquired or inherited.
Acquired AA appears to be an immune-mediated suppression
of the bone marrow and is thus responsive, in most cases,
to immunosuppressive therapy (Miano and Dufour, 2015).
Inherited AA, however, has a complex variety of pathogeneses.
Although many of the patients with BMFS have identifiable
causes, 30–40% of cases still have unknown etiologies, including
cases of inherited AA (Peters et al., 2013). Spontaneous and
engineered models of bone marrow failure have allowed focused
study of these uncharacterized molecular mechanisms. One
such spontaneous model is the autosomal recessive scat (severe
combined anemia and thrombocytopenia) mouse model; scat
carries a missense mutation in the protein-coding Rasa3 gene
(Blanc et al., 2012).
RASA3, a Ras-GTPase Activating Protein (GAP), has
previously been found to play a key role in normal blood
formation. This protein acts to negatively regulate the small
GTPase Ras, and its localization to the membrane is required
for normal function (Fukuda and Mikoshiba, 1996). The specific
Rasa3 mutation in the scat mouse results in the mislocalization
of RASA3 to the cytosol and thus loss of RASA3 function,
which leads to increased levels of active GTP-bound Ras (Blanc
et al., 2012). scat mice interestingly cycle between hematologic
crisis and remission, regardless of the cytosolic localization of
RASA3, suggesting that a secreted factor may mediate the crisis-
remission transition. The first crisis begins in utero and lasts
until ∼P9. Mice that survive the first crisis will progress to
remission, during which there is a striking normalization of
hematologic parameters and physical appearance. Some mice
then enter a second crisis, during which there is over 90%
mortality by 4 weeks of age, likely due to bone marrow failure and
the resulting peripheral pancytopenia (Blanc et al., 2012). Overall,
the mechanism of the cyclic phenotype in scat mouse is unknown
and offers unique opportunities to study the onset and resolution
of bone marrow failure.
In this study, we further characterized the bone marrow failure
in scat and found that RASA3 plays a central role in cell cycle
progression and maintenance of ROS levels during terminal
erythroid differentiation. We observed that in mice undergoing
crisis episodes, the G0/G1 phase is transiently increased at the
basophilic and polychromatophilic stages, suggesting that RASA3
is involved in regulating the G1 checkpoint. In addition, while
ROS levels are normal early in erythropoiesis, we observed an
accumulation of ROS at the reticulocyte stage in scat mice.
However, mitochondria, a potential source of ROS, are eliminated
normally at the reticulocyte stage, suggesting that mitochondrial
metabolism and ROS production may be altered prior to removal.
Surprisingly, apoptosis is not increased, but rather significantly
decreased at several stages of erythroid differentiation in scat
during crisis events. Together, these data suggest that scat is
a model of bone marrow failure with some of the molecular
characteristics of AA. To begin testing the hypothesis that a
secreted factor may be mediating the cyclic phenotype, we also
characterized the differences in the plasma cytokine profile of
scat mice during crisis compared to wild type. We observed
that galectin-1 is significantly decreased in scat mice in crisis
compared to wild type.
MATERIALS AND METHODS
Animals
All experimental mice were 14–21 days old, which corresponds
to the second crisis event of the scat mice. All protocols
were performed according to NIH animal care guidelines, as
approved and enforced by the Institutional Animal Care and Use
Committees at Northwell Health and The Jackson Laboratory.
Erythroblast, Red Cell, and
Plasma/Serum Collection
Bone marrow was flushed and dissociated with cold PBS
containing 0.5% (weight/volume) bovine serum albumin (BSA)
and 2 mM Ethylenediaminetetraacetic acid (EDTA), pH 8.0
(Invitrogen). Spleens were dissociated in cold PBS with 0.5%
BSA only. Cells were filtered using a 70 µm cell strainer and
CD45 depleted using anti-mouse CD45-conjugated microbeads
and magnetic columns as per manufacturer instructions
(Miltenyi). Circulating red cells, containing both reticulocytes
and erythrocytes, were obtained by cardiac puncture. To obtain
plasma or serum, whole blood with or without EDTA was
centrifuged at 600 g for 5 min and the plasma/serum removed.
Erythroid Surface Markers Used for Flow
Cytometry
Terminal erythropoiesis was monitored using CD44, Ter119,
and FSC (Forward Scatter) as markers of differentiation. While
Ter119 is increased during differentiation, CD44 is lost as the
erythroblasts differentiate.
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Depending on the experimental purpose, reticulocyte
maturation was monitored using whether CD71 and Ter119
(ROS content); or MitoTracker Red (MTR) and thiazole orange
(TO, mitochondria analysis). All of these markers except for
Ter119 are lost during reticulocyte maturation.
Reactive Oxygen Species Detection by
Flow Cytometry
Samples were blocked with rat anti-mouse CD16/32 (2.5 µg/106
cells) for 5 min at room temperature (RT) followed by staining
with a cell surface marker cocktail for 15 min at RT protected
from light. Spleen and bone marrow samples were stained with
rat anti-mouse CD44 APC-conjugated (0.5 µg/106 cells), rat anti-
mouse CD45R/CDllb/Ly6G APC-Cy7-conjugated (0.3 µg/106
cells), and rat anti-mouse Ter119 V450-conjugated (0.5 µg/106
cells) for CM-H2DCFDA (DCF, Invitrogen) or rat anti-mouse
Ter119 FITC-conjugated (1 µg/106 cells) for Dihydroethidium
(DHE, Invitrogen). Peripheral blood samples were stained with
rat anti-mouse Ter119 V450-conjugated (0.5 µg/106 cells) and
either rat anti-mouse CD71 PE-conjugated (0.2 µg/106 cells) for
DCF or rat anti-mouse CD71 FITC-conjugated (0.625 µg/106
cells) for DHE. Samples were washed twice in PBS and stained
with either DHE or DCF. DHE diluted in warm IMDM/1% FBS
was added to spleen and bone marrow samples at a 0.4 µM final
concentration, and to RBC at a 4 µM final concentration. DCF
diluted in warm 1x PBS was added at a 25 µM final concentration
for all samples. DHE and DCF were added to the samples
and incubated for 30 min at 37◦C protected from light. All
samples were washed and resuspended for flow analysis. Data was
collected using the BD LSRFortessa cytometer and subsequently
analyzed with FlowJo software. All cell surface marker antibodies
were from BD Biosciences.
Cell Cycle Analysis by Flow Cytometry
Bone marrow cells were isolated and CD45-depleted as above,
blocked with rat anti-mouse CD16/32 (2.5 µg/106 cells) for
5 min at RT, and stained with an antibody cocktail of rat anti-
mouse Ter119 FITC-conjugated (1 µg/106 cells), CD44 APC-
conjugated (0.5 µg/106 cells), and CD45R/CDllb/Ly6G APC-
Cy7-conjugated (0.3 µg/106 cells) for 15 min at RT in the
dark (Liu et al., 2013). Samples were washed in PBS/0.5% BSA,
resuspended in 10 µg/mL Hoechst 33342 (Invitrogen) in warm
IMDM/1%FBS (1 mL/106 cells), and incubated at 37◦C for
30 min in the dark. Samples were resuspended in 500 µL of 1×
PBS with the addition of 0.25 µg of 7AAD (BD Biosciences) to
identify dead cells. Data was collected using the BD LSRFortessa
cytometer and analyzed using FlowJo software.
Cytokine Array
Plasma was separated from circulating red cells as described
above and then frozen at −80◦C until future use. Cytokine
levels were semi-quantitated using the Abcam 97-target Mouse
Cytokine Antibody Array according to the manufacturer’s
protocol (ab169820). Briefly, plasma samples were diluted
1:20 in the 1× blocking buffer provided. Membranes were
imaged with the Bio-Rad ChemiDocTM MP. Quantification was
performed using Gilles Carpentier’s Dot Blot Analyzer for ImageJ
from the ImageJ website macros/toolsets folder, according to
documentation at image.bio.methods.free.fr/dotblot.html.
ELISA Analysis of Galectin-1 Levels in
Mouse Plasma and Serum
Plasma samples were obtained as mentioned above, and serum
samples were obtained in the same manner but without
the use of EDTA. Both plasma and serum samples were
used to demonstrate consistency across collection methods
(de Jager et al., 2009). Prior to loading, all samples were
diluted 1:10 in dilution buffer provided with Abcam’s Mouse
Galectin 1 ELISA Kit (ab119595), and the kit was run
according to manufacturer’s protocol. The plate was read on a
spectrophotometer at 450 nm at RT. Galectin-1 concentrations
of each sample were extrapolated using the standard curve
created on Microsoft Excel and analyzed by comparing scat and
wild type measures by unpaired t-test using GraphPad Prism
software.
Apoptosis Analysis by Flow Cytometry
Apoptosis was assessed using Annexin V as per manufacturer
(BD Biosciences). All samples were stained with the cell surface
marker antibodies as discussed in the cell cycle methods section,
followed by staining with Annexin V and 7AAD. The protocol
was modified by using 1 µg of Annexin V and 0.25 µg of
7AAD for 1 × 106 cells. Apoptosis data was collected using
the BD LSRFortessa cytometer and analyzed using FlowJo
software.
Mitochondria Analysis
Mitophagy was assessed using MitoTracker Red CMXRos (MTR;
Molecular Probes) and TO (BD Biosciences) as described (Zhang
et al., 2009). Doubly stained reticulocytes were obtained by
sequential staining with MTR, then TO. MTR fluorescence
emission between 600 and 620 nm was collected after 562 nm
laser excitation using a BD LSR II flow cytometry analyzer (BD
Biosciences).
Transmission Electron Microscopy
For analysis by transmission electron microscopy, peripheral
blood reticulocytes and red cells were fixed in 4%
paraformaldehyde, 0.1% glutaraldehyde, and 1% sucrose
in 0.1 M cacodylate buffer for 1 h at 4◦C, then washed in
0.1 M buffer at pH 7.4; remaining aldehydes were quenched
with 50 mM ammonium chloride. The fixed cells were then
dehydrated and embedded in LR-White Resin, sectioned to
50–70 nm thickness, and examined in a Philips-410 electron
microscope.
Statistics
Statistical evaluations between different experimental
groups were performed using GraphPad Prism 7 (unpaired
t-test) and p < 0.05 was considered to indicate statistical
significance.
Frontiers in Physiology | www.frontiersin.org 3 June 2018 | Volume 9 | Article 689
fphys-09-00689 June 1, 2018 Time: 13:27 # 4
Hartman et al. RASA3-Mediated Defects in scat
FIGURE 1 | Hoechst staining reveals altered cell cycling in the basophilic and polychromatophilic stages of erythropoiesis in scat mice. (A) Gating of CD45-depleted,
Ter119 positive bone marrow cells based on CD44 surface expression in wild type and scat. (B) Wild type and scat cells were stained with Hoechst dye (10 µg/mL)
and analyzed as individual erythropoietic populations by flow cytometry. (C) Representative cell cycle patterns are suggestive of an accumulation of cells in the
G0/G1 phase during erythropoiesis in scat mice. Representative pattern from five independent experiments.
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RESULTS
scat Presents With Cell Cycle Defects at
the Basophilic and Polychromatophilic
Stages
We previously reported an accumulation of erythroid precursors
at the polychromatophilic and orthochromatic stages in the
scat mouse model (Blanc et al., 2012), suggesting potential cell
cycle defects. Therefore, we isolated the bone marrow from wild
type and scat mice and measured the cell cycle progression
at each of the erythroid differentiation stages using the DNA-
binding dye Hoechst-33342 along with the erythroid cell surface
markers CD44, Ter119, and FSC. Throughout differentiation,
erythroid cells lose the adhesion molecule CD44, gain the
membrane glycoprotein associated-Ter119, and decrease in size,
allowing analysis of distinct developing populations (Liu et al.,
2013; Figure 1A). While the pattern was similar between
wild type and scat within the proerythroblast population, we
observed different patterns of DNA content at the basophilic and
polychromatophilic stages that demonstrate a failure to progress
out of G0/G1 into S or G2 in scat, indicating a defect at the
G1 checkpoint. However, we observed that the pattern either
normalizes or becomes indiscernible by the orthochromatic
stage, as orthochromatic erythroblasts in both scat and wild type
mice are almost entirely in the G0/G1 phase, consistent with
previously published studies (Pop et al., 2010; Figures 1B,C).
Thus, we conclude that Rasa3 plays a critical role in the G1
checkpoint at the basophilic and polychromatophilic stages of
erythroid differentiation.
Reactive Oxygen Species (ROS)
Accumulate at the Proerythroblastic and
Reticulocyte Stages in scat
Having shown that the cell cycle is altered specifically at the
basophilic and polychromatophilic stages, we then hypothesized
that increased levels of ROS could be involved in the mechanism
leading to crisis in scat. To evaluate cytosolic peroxide and
superoxide generation in wild type and scat, we used DCF
and DHE, respectively, as previously described by George et al.
(2013). We assessed ROS production in the spleen, bone marrow,
and peripheral blood of the mice. A qualitative overlay of the
superoxide and general oxidative stress signals in the spleens of
wild type and scat indicate a relatively similar level of ROS levels
(Figure 2A). However, when we quantified these ROS levels,
we observed a significant increase in the peroxide levels at the
proerythroblastic stage of scat spleen (Figure 2B; P < 0.05). We
also noticed a trend toward increased levels of ROS throughout
erythroid differentiation (Figure 2B, left panel). The same trend
is observed in the bone marrow (Supplementary Figure 1). This
increase in ROS does not seem to be due to an increase in
cytosolic superoxide, as DHE levels remain unchanged in scat
throughout differentiation, and comparable to those observed in
WT (Figure 2B, right panel and Supplementary Figure 1).
Reactive oxygen species play a role in the regulation of the
red cell lifespan (Friedman et al., 2004). Therefore, we evaluated
these ROS levels in the peripheral blood of the mice. By using
CD71 and Ter119 as markers, one can discriminate between
reticulocytes and erythrocytes (Figure 3A). Due to the young
age of the mice (less than 3 weeks old), there is a noticeable
FIGURE 2 | There is an increase in peroxide levels at the proerythroblastic stage of erythropoiesis in the spleen of scat mice. (A) Representative histograms showing
the levels of DCF (four left panels) and DHE (four right panels) in the spleen measured as fluorescence intensity. (B) Quantification of DCF and DHE levels by
population in the spleen of wild type and scat mice. Measured as fold change normalized to wild type (n = 6 for DCF and n = 14 for DHE).
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FIGURE 3 | Increased ROS in scat crisis reticulocytes. (A) Representative gating of reticulocytes and erythrocytes based on levels of CD71 in wild type and scat
peripheral blood. (B) Representative histograms showing the levels of DCF measured as fluorescence intensity in reticulocytes and erythrocytes. (C) Quantification of
DCF levels in reticulocytes and erythrocytes based on fold change. (D) Representative histograms showing the levels of DHE measured as fluorescence intensity in
reticulocytes and erythrocytes. (E) Quantification of DHE levels in reticulocytes and erythrocytes based on fold change (n = 11 for DCF and n = 9 for DHE).
amount of reticulocytes in the bloodstream of WT animals.
We observed that the trend toward increased DCF levels seen
in the spleen (Figure 2B) is also present in scat reticulocytes
(Figures 3B,C, upper panels). However, the increased levels of
ROS normalize during reticulocyte maturation, as erythrocytes
do not show an increase in DCF (Figures 3B,C, lower panels).
Surprisingly, and unlike what we observed in the spleen, DHE
levels are increased 1.4 times in scat reticulocytes compared
to WT (Figures 3D,E, upper panels; P = 0.02). Nevertheless,
this increase is transient, and the DHE levels normalize at the
erythrocyte stage (Figures 3D,E, lower panels). Taken together,
these results suggest that there is a transient increase in ROS, both
early and late in erythroid differentiation in scat.
Mitochondria Are Eliminated Normally at
the Reticulocyte Stage in the scat Mice
Mitochondria are an important source of ROS and are among
the last organelles to be eliminated at the reticulocyte stage (Ney,
2011). Therefore, we assessed mitochondrial clearance during
reticulocyte maturation in both WT and scat using MTR and
TO as markers for mitochondria and reticulocyte maturation by
RNA content, respectively. As shown in Figure 4A, no evidence
of abnormal mitochondrial retention is seen in scat. While there
is an increased overall number of reticulocytes in scat compared
to WT due to the compensatory reticulocytosis, there are no
TO−/MitR+ events, indicating no mature reticulocytes (TO−)
with mitochondria present. In addition, electron microscopy
performed on the peripheral blood of WT and scat animals
demonstrates that no aberrant mitochondria are observed in
the scat reticulocytes (Figure 4B). Thus, we conclude that the
increased ROS levels observed at the reticulocyte stage are not
a byproduct of improper mitochondria elimination.
Apoptosis Is Decreased in scat During
Erythropoiesis
Given the increased ROS in the reticulocytes and the overall
cellular stress associated with the bone marrow failure observed
in scat, we elected to investigate apoptosis at each stage
of erythroid differentiation in the bone marrow and spleen.
To do so, we used the markers Annexin V and 7AAD in
addition to CD44, Ter119, and FSC as described previously
(Liu et al., 2013). No significant increase in the overall
percentage of early apoptotic (Annexin V+ 7AAD−), late
apoptotic (Annexin V+ 7AAD+), or necrotic (Annexin V−
7AAD+) cells in scat were seen compared to their littermate
controls. However, we observed a significant decrease in
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FIGURE 4 | Mitochondria are removed normally during erythropoiesis in scat
mice. (A) Analysis of wild type and scat peripheral blood by flow cytometry
using markers for mitochondria (MitR) and RNA content of reticulocytes (TO).
Early reticulocytes are ribosome-positive, mitochondria-positive (upper right
quadrant), late reticulocytes ribosome-positive, mitochondria-negative (lower
right quadrant), and retained mitochondria ribosome-negative,
mitochondria-positive (upper left quadrant). No evidence for increased
mitochondrial retention is seen. Representative pattern from five independent
experiments. (B) Electron microscopy of RBCs in wild type and scat mice
shows no evidence of mitochondria retention.
the percentage of late apoptotic cells in the bone marrow
(Supplementary Figure 2; P < 0.05). Additionally, when we
quantified early apoptosis based on each individual erythroid
population, we noticed a significant decrease in apoptosis in both
scat bone marrow and spleen proerythroblastic, polychromatic,
and orthochromatic stages (Figures 5A,B; P < 0.05). Together,
these data suggest that loss of function inRasa3 leads to decreased
apoptosis.
scat Mice Demonstrate Decreased
Plasma and Serum Levels of Galectin-1
One of the most striking aspects of the scat phenotype is the cyclic
remission that includes normalization or near normalization
of hematologic parameters and external physical manifestations
of anemia and thrombocytopenia. The fact that remission
occurs without a correction to RASA3’s aberrant location in
the cytosol led to the hypothesis that a secreted factor may
be mediating its onset. To test this hypothesis, we analyzed
plasma cytokine profiles by cytokine array and identified
several targets of interest, including galectin-1 (Figure 6A).
Galectin-1 is a known mediator of stromal cell-to-stem cell
interactions and transduction of intracellular signaling in the
bone marrow hematopoietic niche (Liu and Rabinovich, 2010;
Rabinovich and Vidal, 2011), and its levels were significantly
decreased in scat mice during crisis compared to wild type
(Figure 6B, 23326.5 ± 21439.72 vs. 31019.63897 ± 20110.65161;
P < 0.05), making it our initial focus. Interestingly, well-
known inflammatory mediators such as IL-1β and IL-6, were
not significantly different between wild type and scat. To verify
these results, we performed an ELISA on serum and plasma
samples from scat and littermate wild type mice and indeed
found significantly decreased levels of galectin-1 in samples
from scat mice (Figure 6C, 2487.917 ± 606.1 pg/mL vs.
5562.417 ± 652.4 pg/mL; P < 0.05). Together, these results
suggest that galectin-1 may play a role in the cyclic phenotype or
serve as a biomarker of the crisis-remission transition observed
in scat.
DISCUSSION
In this study, we elucidate mechanisms contributing to anemia
in scat mice during crisis events and propose a model in
which loss of RASA3 function during erythropoiesis leads to
dysregulation of several key cellular processes with the final
result of anemia (Figure 7). In the bone marrow and spleen,
impaired cell cycle progression and increased ROS inhibit proper
proliferation and terminal differentiation, leading to eventual
decreased red cell output, despite decreased apoptosis. In the
periphery, increased ROS further contribute to anemia and
secreted factors such as galectin-1 have a yet to be elucidated
role in modulating erythropoiesis. The scat model is very
unique in the context of existing mouse models of inherited
bone marrow failures. Most current models focus on the
immune-mediated pathogenesis of acquired AA (Scheinberg
and Chen, 2013), and models of congenital AA have focused
on mutations in DNA-repair pathways, such as the Fanc−/−
models and more recent Brca−/− model (Parmar et al., 2009;
Vasanthakumar et al., 2016). Therefore, scat and its loss of
function mutation in Rasa3 implicate a unique signaling axis in
congenital AA. Further, though these other models of congenital
AA have similar hematopoietic defects and possibly convergent
molecular mechanisms, scat is the only existing model with a
cyclic phenotype that offers key opportunities to study both
the onset and remission of some aspects of bone marrow
failure.
Cell cycle progression and erythropoiesis are intricately co-
regulated. Proper alignment of cell cycle status with phases
of erythroid maturation is crucial for regulating the transition
from proliferative progenitors to increasingly differentiated
precursors, allowing production of a sufficient number of
fully mature red cells. Known cell cycle regulators have
been shown to play key cell-intrinsic roles in promoting
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FIGURE 5 | Early apoptosis is significantly decreased in scat mice at three distinct erythroid populations. (A) Quantification of early apoptosis in the bone marrow of
wild type and scat mice at the proerythroblastic, basophilic, polychromatophilic, and orthochromatic erythroid differentiation stages. (B) Quantification of early
apoptosis in the spleen of wild type and scat mice at the proerythroblastic, basophilic, polychromatophilic, and orthochromatic erythroid differentiation stages (n = 3).
FIGURE 6 | Levels of specific cytokines, including galectin-1, are altered in scat plasma and serum. (A) Analysis of plasma samples from scat and littermate WT
mice by cytokine array reveals significant differences in four cytokines: galectin-1, amphiregulin, Axl, IGFBP-6, and no significant difference in levels of IL-1B (n = 3).
(B) Quantification of the fold change of the cytokines specified in A; galectin-1: p = 0.0154, amphiregulin: p = 0.0366, Axl: p = 0.0135, IGFBP-6: p = 0.0011, IL-1B:
p = 0.5825. (C) ELISA analysis of plasma and serum samples diluted 1:10 verifies significantly decreased levels of galectin-1 in scat samples compared to littermate
WT (n = 15; p = 0.0018). ∗p < 0.05 and ∗∗p < 0.01.
terminal erythroid differentiation (Sankaran et al., 2008).
Further, Ras/Raf/MEK/ERK and Ras/PI3K/Akt pathways are
known to control the transcription or regulation of key cell
cycle regulators (Lee et al., 2008). Therefore, we examined
the cell cycle status of individual erythroid differentiation
populations in wild type and scat bone marrow. Our results
demonstrate a pattern of accumulation in the G0/G1 phase
in scat, suggestive of a defect at the G1 checkpoint that
normalizes or becomes indiscernible by the orthochromatic
stage. During normal erythropoiesis, most orthochromatic
erythroblasts have exited the cell cycle and entered G0/G1.
The G1 checkpoint integrates various intracellular signaling
cascades, including pathways downstream of Ras, and either
promotes or prevents DNA replication. Because loss of RASA3
function leads to increased active, GTP-bound Ras in scat,
changes in Ras signaling pathways are likely influencing cell cycle
progression. As mentioned above, the polychromatophilic to
orthochromatic transition represents a key point of cell cycle exit
during erythropoiesis that allows final terminal differentiation
and enucleation. Prior work characterizing the erythroid
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FIGURE 7 | Model of the mechanisms of anemia in the scat mouse model. Mutant RASA3 is rendered non-functional by its mislocalization to the cytosol, leading to
dysregulated Ras signaling throughout erythroid differentiation. This dysregulated signaling is associated with an accumulation in the G0/G1 phase of the cell cycle in
early erythroid precursors, impairing proper proliferation and differentiation and contributing to decreased red cell mass, despite decreased apoptosis in these
populations. A block in terminal differentiation with an accumulation at the polychromatic/orthochromatic stages, as well as increased ROS accumulation in the
reticulocyte stage further contribute to the anemia seen as a result of the loss of functional RASA3. Secreted factors, such as galectin-1, may contribute to mediating
remission in the erythropoietic microenvironment while RASA3 remains mislocalized.
differentiation defect in scat demonstrated an accumulation
specifically at the polychromatophilic/orthochromatic stages.
This accumulation therefore aligns with and supports the
notion of aberrant cell cycling in scat erythropoiesis. Finally,
many inherited BMFS have a predisposition for hematologic
malignancies that are characterized by dysregulated cell cycling
(Al-Rahawan et al., 2008). Therefore, the altered cell cycle
profiles observed in scat further support its characterization
as a model of inherited bone marrow failure. Future work
will characterize exactly which cell cycle regulators are being
affected and how altered Ras signaling mediates these changes.
We will notably investigate the role played by cyclins and
CDKs in the regulation of the cell cycle. Due to the
fragile nature of the scat mice in crisis, we were unable to
inject Bromodeoxyuridine (BrdU) that would have allowed
quantification of individual G0/G1, S, and G2/M phases.
However, even with our current methods, we were able to
observe this consistent trend toward G0/G1 accumulation in
scat.
We also identified increased ROS in scat, most notably the
accumulation of superoxide in reticulocytes. ROS are known to
negatively impact RBC health and lifespan, indicating that their
increase likely contributes to the anemia of scat (Friedman et al.,
2004). RASA3 is a known negative regulator of Ras activity, and
previous studies have determined that upregulation of active Ras
proteins can lead to increased intracellular ROS concentrations,
further supporting a role for ROS in the scat phenotype
(Zamkova et al., 2013). Impaired hemoglobin formation can also
be a source of ROS. Accordingly, we previously documented
hemoglobinization defects in scat (Blanc et al., 2012). Further
studies will elucidate the mechanism(s) of increased ROS
during erythropoiesis in scat by examining the activity of Ras
isoforms, mitochondrial metabolism prior to proper removal,
and hemoglobin synthesis. A surprising finding of the present
work is the decrease in apoptosis seen in scat erythroid
populations. Given the anemia and overall poor health of scat,
one might expect to see an increase in apoptosis; however,
this was not the case. Active H, K, and N-Ras are oncogenic
proteins known to play a significant role in cell proliferation.
Previous studies have shown that an overexpression of Ras
isoforms leads to a block in terminal erythroid differentiation
accompanied by increased proliferation of earlier erythroid
populations (Zhang et al., 2003). Additionally, the same
study demonstrated that the introduction of oncogenic Ras
into erythroleukemia cells resulted in a block in terminal
differentiation and extended proliferation with no effect on
apoptosis (Zhang et al., 2003). This ability of precursor cells to
survive and proliferate longer due to increased Ras signaling
seen with loss of RASA3’s negative regulation could potentially
explain why apoptosis is decreased in scat compared to wild
type mice. The mechanism of the interesting cyclic phenotype
of the scat mouse has yet to be elucidated and likely holds key
insights into general mechanisms of onset and resolution of
BMFS. We hypothesized that secreted factors may be playing
a role in mediating remission and thus compared the plasma
cytokine profiles of scat crisis and wild type mice. Galectin-
1 was consistently decreased in scat compared to wild type,
but levels of common inflammatory mediators such as IL-6
and IL-1β were unchanged. Galectins, a family of β-galactoside
binding proteins, have been shown to play key roles in the
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bone marrow niche and the erythroblastic island, indicating that
these lectins have the capacity to modulate the maturation of
hematopoietic cells. Within the bone marrow niche, galectins are
known mediators of stromal cell-hematopoietic cell interactions
(Rabinovich and Vidal, 2011). Galectin-5, a member of the
same subfamily as galectin-1, has been specifically implicated
in protein sorting and regulation of exosomal uptake in rat
erythroblastic islands (Barres et al., 2010). Further, galectins are
also known modulators of various mitogen-activated protein
kinase (MAPK) signaling pathways in several cell types, including
key pathways (PI3K/Akt, Raf/Mek/MAPK) downstream of Ras
that are likely to be altered with loss of RASA3 (Masamune
et al., 2006; Shimizu et al., 2009). In this context, the
ability of galectin-1 to modulate these signaling pathways
is of great interest. Though existing data is intriguing and
suggestive of galectin-1’s importance, future studies will be
required to prove any mechanistic role for galectin-1 in the
cyclic bone marrow failure phenotype, rather than its decrease
simply being an effect of loss of RASA3 function across all
cell types in the mouse, or a generic serum biomarker of
disease.
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